Want to see ZOMDF full AI Analyst Report?

Zomedica (ZOMDF) Price & Analysis

4,815 Followers

ZOMDF Stock Chart & Stats

$0.11

Market closed

$0.11

Day’s Range― - ―

52-Week Range$0.04 - $0.16

Previous CloseN/A

VolumeN/A

Average Volume (3M)2.43M

Market Cap

$84.28M

Enterprise Value-$15.91M

Total Cash (Recent Filing)$76.88M

Total Debt (Recent Filing)$2.08M

Price to Earnings (P/E)―

Beta0.15

Next Earnings

Aug 12, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.06

Shares Outstanding979,949,650

10 Day Avg. Volume1,820,838

30 Day Avg. Volume2,427,286

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market Cap-0.19

Enterprise Value/Revenue-0.60

Enterprise Value/Gross Profit-1.08

Enterprise Value/Ebitda0.29

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusModerate Buy

Number of Analyst Covering0

EPS Forecast (FY)-0.03

Revenue Forecast (FY)$45.33M

Bulls Say, Bears Say

Bulls Say

Financial PerformanceFinancial results show continued growth in an expanding market, meeting growth expectations both sequentially and in year-over-year comparisons.

Product InnovationZomedica has introduced several new assays for use with its TRUFORMA diagnostics platform, allowing veterinary practices to run tests without sending samples to an outside lab.

Sales GrowthThe TRUFORMA assays have been one of the sources of sales growth over the past year.

Bears Say

Price WeaknessAlthough Zomedica has made fundamental progress, the price weakness led to delisting and further price weakness.

Stock Price And DelistingThe closing price of Zomedica stock fell below $0.10 per share, forcing the delisting of ZOM shares.

Zomedica News

Zomedica Shareholders Back Board But Reject Executive Pay

Zomedica ( ($ZOMDF) ) has issued an announcement. Zomedica, a veterinary health company focused on companion animals, held...

1M ago

Astera Labs, Axon, Zomedica, Microchip and TeraWulf Shock

Insiders have been trading these 5 stocks: (($ALAB)), (($AXON)), (($ZOMDF)), (($MCHP)) and (($WULF)). Here is a breakdown of...

2M ago

ALAB

AXON

Seagate, Schwab, Zomedica, Kratos, Astera Insider Shock

Insiders have been trading these 5 stocks: (($STX)), (($SCHW)), (($ZOMDF)), (($KTOS)) and (($ALAB)). Here is a breakdown of...

2M ago

STX

ALAB

Seagate, Schwab, Zomedica, Constellation, Lumentum Shake Markets

Insiders have been trading these 5 stocks: (($STX)), (($SCHW)), (($ZOMDF)), (($STZ)) and (($LITE)). Here is a breakdown of...

2M ago

STX

STZ

HPE, Charles Schwab, Zomedica, Illumina, Circle Insider Shake-Up

Insiders have been trading these 5 stocks: (($HPE)), (($SCHW)), (($ZOMDF)), (($ILMN)) and (($CRCL)). Here is a breakdown of...

2M ago

HPE

CRCL

Zomedica Posts Record 2025 Revenue as New Services and Cost Cuts Lift Margins

Zomedica ( ($ZOMDF) ) has issued an announcement. Zomedica reported record fourth-quarter 2025 revenue of $10.5 million and...

4M ago

Zomedica Reports Record Revenue Growth in Q3 2025

Zomedica Pharma ( ($ZOMDF) ) has released its Q3 earnings. Here is a breakdown of the information Zomedica...

9M ago

ZOMDF

Zomedica Achieves Record Third Quarter Revenue Growth in 2025

Zomedica ( ($ZOMDF) ) has issued an announcement. Zomedica announced a 16% increase in revenue for the third...

9M ago

Zomedica Corp. Reports Q2 2025 Financial Results

Zomedica Pharma ( ($ZOMDF) ) has released its Q2 earnings. Here is a breakdown of the information Zomedica...

11M ago

ZOMDF

Zomedica Achieves Record Revenue Growth in Q2 2025

Zomedica ( ($ZOMDF) ) has provided an update. Zomedica reported a 14% increase in revenue for the second...

12M ago

ZOMDF FAQ

What was Zomedica’s price range in the past 12 months?

Zomedica lowest stock price was $0.04 and its highest was $0.16 in the past 12 months.

What is Zomedica’s market cap?

Zomedica’s market cap is $84.28M.

When is Zomedica’s upcoming earnings report date?

Zomedica’s upcoming earnings report date is Aug 12, 2026 which is in 21 days.

How were Zomedica’s earnings last quarter?

Zomedica released its earnings results on May 06, 2026. The company reported $0 earnings per share for the quarter, the consensus estimate of N/A by $0.

Is Zomedica overvalued?

According to Wall Street analysts Zomedica’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Zomedica pay dividends?

Zomedica does not currently pay dividends.

What is Zomedica’s EPS estimate?

Zomedica’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Zomedica have?

Zomedica has 979,949,650 shares outstanding.

What happened to Zomedica’s price movement after its last earnings report?

Zomedica reported an EPS of $0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went up 11.957%.

Which hedge fund is a major shareholder of Zomedica?

Currently, no hedge funds are holding shares in ZOMDF

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Zomedica Stock Smart Score

Neutral

Fundamentals

Return on Equity

―

Trailing 12-Months

Asset Growth

-15.01%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Zomedica

Zomedica Pharmaceuticals Corp. operates as a development stage veterinary diagnostic and pharmaceutical company. It creates products for companion animals by focusing on the unmet needs of clinical veterinarians. The company was founded by Gerald L. Solensky, Jr. on January 7, 2013 and is headquartered in Ann Arbor, MI.